Cargando…
Sustained-Release Corticosteroid Options
Sustained-release corticosteroid treatment has shown to be a promising strategy for macular edema due to retinovascular disease (i.e., diabetes and retinal vein occlusion) and for the treatment of noninfectious posterior uveitis. Clinicians now have the option of three sustained-release corticostero...
Autores principales: | Cabrera, Mariana, Yeh, Steven, Albini, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130028/ https://www.ncbi.nlm.nih.gov/pubmed/25140246 http://dx.doi.org/10.1155/2014/164692 |
Ejemplares similares
-
Pharmacokinetic Evidence of Steady and Sustained Drug Release from
Long-Acting Implantable Corticosteroid Matrices for Chronic
Rhinosinusitis
por: Ow, Randall A., et al.
Publicado: (2022) -
Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review
por: Kankaanranta, Hannu, et al.
Publicado: (2004) -
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
por: Caixàs, Assumpta, et al.
Publicado: (2014) -
Treatment of immunothrombosis dysregulation: high-dose corticosteroids is not the good option
por: Helms, Julie, et al.
Publicado: (2023) -
Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?
por: Coelho, Ana Luísa, et al.
Publicado: (2016)